Ferndale Pharma Group

Name

Ferndale Pharma Group

Legal name

Ferndale Pharma Group, Inc.

Website

https://ferndalepharmagroup.com

Company type

Private

Founded year

1897

Operating status

Operating

Ownership category

akta.pro rank

Product category

Specialty Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Management of Companies and Enterprises (551)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industry

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

• Specialty pharmaceuticals
• Dermatology products
• Contract manufacturing
• Hospital healthcare
• Topical skincare

Headquarters

HQ city

Ferndale

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical and OTC Product Sales: Ferndale Pharma Group generates revenue through the sale of specialty pharmaceutical products, OTC skincare brands, and dermatological solutions. The company develops and manufactures products through its subsidiaries and sells them through retail, hospital, and direct channels.
2. Contract Manufacturing Services: Ferndale Contract Manufacturing provides pharmaceutical production, quality control, quality assurance, product development, warehousing, and distribution services to external customers through its FDA-approved facility.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels2 records

Core offering

Ferndale Pharma Group is a privately held holding company that develops, manufactures, and distributes specialty dermatology and topical pharmaceutical products through its subsidiaries. It operates Eloquest Healthcare (hospital-focused dermatology and infection-prevention solutions), Ferndale Contract Manufacturing (CDMO services), Ferndale Worldwide (international out-licensing), and Ferndale Pharma UK (dermo-cosmetic skincare and topical therapeutics). Core products include medical adhesives Mastisol and Detachol for clinical use.

Product overview

Ferndale Pharma Group, Inc. is a pharmaceutical holding company founded in 1897 that operates multiple specialty healthcare subsidiaries: Eloquest Healthcare (dermatology specialty serving hospitals with infection prevention and skin integrity products), Ferndale Labs & Contract Manufacturing (FDA-approved CDMO with 100,000+ sq ft facility), Ferndale Worldwide (international out-licensing to 20+ markets), and Ferndale Pharma UK (UK dermatology partner with AESTHETICARE, HEALTH & BEAUTY, and MEDICAL divisions). The group also previously owned OTC skincare brands DerMend and Recticare, sold in January 2026. Products include medical adhesives Mastisol and Detachol. The company provides contract manufacturing, in-licensing, acquisition, and out-licensing partnership opportunities.

Differentiator

Problem solved

Functional benefit

Brands

• Ferndale Labs & Contract Manufacturing: Contract Development and Manufacturing Organization offering pharmaceutical, topical drugs, and related market services for over 30 years.
• Eloquest Healthcare
• Ferndale Worldwide
• Ferndale Pharma UK

Products and services

• Eloquest Healthcare Dermatology specialty subsidiary serving hospitals, healthcare practitioners, and patients with intuitive, cost-effective solutions for prevention of hospital acquired infections, skin integrity, dermal pain minimization, and device adhesion.
• Ferndale Contract Manufacturing (CDMO Services) Contract Development and Manufacturing Organization offering pharmaceutical production, quality control, quality assurance, product development, warehousing, and distribution services for pharma, topical drugs, and related markets. Operated from an FDA-approved 100,000+ sq ft facility in Ferndale, Michigan with over 30 years of manufacturing experience.
• Ferndale Worldwide International business division focused on out-licensing products to local partners globally, exporting finished and bulk products from the US base to more than 20 markets worldwide.
• Ferndale Pharma UK UK-based dermatology and skincare company operating three divisions: AESTHETICARE (professional anti-ageing skincare for aesthetic clinics), HEALTH & BEAUTY (consumer and dermatologist skin solutions), and MEDICAL (skin medicines for pain related to skin procedures). Serves as exclusive UK partner for Cantabria Labs.
• Mastisol Medical adhesive product used in clinical and hospital applications, with Safety Data Sheets maintained through Ferndale Pharma Group.
• Detachol Medical adhesive remover product for clinical applications, with Safety Data Sheets maintained through Ferndale Pharma Group.

Named customers5 records

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Cantabria LabscoreStrategic or Co-development PartnerFerndale Pharma UK serves as the exclusive UK partner for Cantabria Labs dermatological innovators headquartered in Spain. This is a core strategic partnership for the UK market focused on dermo-cosmetic skincare and specialized skin medicines.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Patheon (Thermo Fisher Scientific): Global CDMO within Thermo Fisher that provides pharmaceutical development and manufacturing services. Comparable to Ferndale's CDMO subsidiary, though operating at vastly greater scale and breadth.
• Perrigo Company: Major OTC consumer healthcare company with dermatology, skincare, and store-brand products distributed through retailers and pharmacies. Comparable to Ferndale's former OTC skincare franchise (DerMend, Recticare) and retail distribution.
• Catalent: Large global CDMO offering formulation, manufacturing, and packaging services across dosage forms. Comparable to Ferndale Labs & Contract Manufacturing, though at significantly larger scale and broader service mix.
• Bayer (Consumer Health / Pharmaceuticals): Diversified life sciences company with significant dermatology, OTC, and prescription pharma franchises. Overlaps with Ferndale's hospital dermatology, OTC skincare, and pharmacy distribution channels.

Direct peers

• Almirall: European dermatology-focused specialty pharma company with prescription and dermo-cosmetic products across hospital and pharmacy channels. Comparable to Ferndale's specialty dermatology positioning and UK/European footprint.
• Pierre Fabre: French pharmaceutical and dermo-cosmetic group with strong hospital, pharmacy, and aesthetic dermatology presence. Comparable to Ferndale's mix of Rx dermatology, dermo-cosmetics, and hospital channel products.
• Galderma: Pure-play dermatology pharmaceutical company offering prescription and aesthetic/dermo-cosmetic products. Closely comparable to Ferndale Pharma UK's AESTHETICARE and Eloquest's dermatology focus, though at much larger scale.
• Mission Pharmacal: Privately held US specialty pharmaceutical company focused on niche therapeutic areas including dermatology and women's health. Comparable to Ferndale as a private specialty pharma with hospital and physician channel focus.
• Crown Laboratories: Specialty pharmaceutical and dermatology company with branded Rx and OTC skincare products, plus a CDMO business. Directly comparable to Ferndale's mix of hospital-channel dermatology, consumer skincare, and contract manufacturing.

Emerging players

• Aclaris Therapeutics: Clinical-stage and commercial dermatology company developing and commercializing therapies for skin and immune-mediated conditions. Emerging niche player with meaningful overlap to Ferndale's specialty dermatology focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ferndale-pharma-group-inc.

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ferndale Pharma Group